Jacob Kimmel
@jacobkimmel.bsky.social
co-founder & president @newlimitbio.bsky.social | Prev PI @calico, PhD @ucsf | interested in aging, machine learning, genomics, & the technology production function
https://jck.bio
https://jck.bio
we remodeled also @newlimitbio.bsky.social hq.
we stole design ideas from bell labs & skunk works, then added glass everywhere to mimic the future we're trying to build.
we're all excited for the discoveries to come in our new space.
we stole design ideas from bell labs & skunk works, then added glass everywhere to mimic the future we're trying to build.
we're all excited for the discoveries to come in our new space.
November 23, 2024 at 6:16 PM
we remodeled also @newlimitbio.bsky.social hq.
we stole design ideas from bell labs & skunk works, then added glass everywhere to mimic the future we're trying to build.
we're all excited for the discoveries to come in our new space.
we stole design ideas from bell labs & skunk works, then added glass everywhere to mimic the future we're trying to build.
we're all excited for the discoveries to come in our new space.
discovering TF sets that reverse cell age is only the first step to making a medicine. next, we'll need to formulate these TF sets into drugs.
@newlimitbio.bsky.social is leveraging LNP-mRNA technology to achieve this, similar to the COVID vaccines.
@newlimitbio.bsky.social is leveraging LNP-mRNA technology to achieve this, similar to the COVID vaccines.
November 23, 2024 at 6:16 PM
discovering TF sets that reverse cell age is only the first step to making a medicine. next, we'll need to formulate these TF sets into drugs.
@newlimitbio.bsky.social is leveraging LNP-mRNA technology to achieve this, similar to the COVID vaccines.
@newlimitbio.bsky.social is leveraging LNP-mRNA technology to achieve this, similar to the COVID vaccines.
our Metabolism team developed 2 gold-standard pre-clinical models for hepatocytes.
consistent with our previous results, old hepatocytes are more susceptible to damage than young in both settings.
consistent with our previous results, old hepatocytes are more susceptible to damage than young in both settings.
November 23, 2024 at 6:16 PM
our Metabolism team developed 2 gold-standard pre-clinical models for hepatocytes.
consistent with our previous results, old hepatocytes are more susceptible to damage than young in both settings.
consistent with our previous results, old hepatocytes are more susceptible to damage than young in both settings.
We've ported our Engine technology to human hepatocytes and received our first in vivo screening results
to our knowledge, these are the first in vivo screening data for human hepatocytes & the first 70 reprogramming sets tested to date. already we're seeing promising signals.
to our knowledge, these are the first in vivo screening data for human hepatocytes & the first 70 reprogramming sets tested to date. already we're seeing promising signals.
November 23, 2024 at 6:16 PM
We've ported our Engine technology to human hepatocytes and received our first in vivo screening results
to our knowledge, these are the first in vivo screening data for human hepatocytes & the first 70 reprogramming sets tested to date. already we're seeing promising signals.
to our knowledge, these are the first in vivo screening data for human hepatocytes & the first 70 reprogramming sets tested to date. already we're seeing promising signals.